View ValuationThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsAgroFresh Solutions 향후 성장Future 기준 점검 0/6핵심 정보n/a이익 성장률n/aEPS 성장률Chemicals 이익 성장42.1%매출 성장률n/a향후 자기자본이익률n/a애널리스트 커버리지Low마지막 업데이트31 Mar 2023최근 향후 성장 업데이트업데이트 없음모든 업데이트 보기Recent updatesReported Earnings • Mar 11Full year 2022 earnings released: US$1.15 loss per share (vs US$0.59 loss in FY 2021)Full year 2022 results: US$1.15 loss per share (further deteriorated from US$0.59 loss in FY 2021). Revenue: US$161.9m (down 2.4% from FY 2021). Net loss: US$59.8m (loss widened 97% from FY 2021). Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth.Buying Opportunity • Nov 19Now 20% undervaluedOver the last 90 days, the stock is up 50%. The fair value is estimated to be €3.34, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 4.9%. For the next 3 years, revenue is forecast to grow by 10% per annum. Earnings is also forecast to grow by 30% per annum over the same time period.Board Change • Nov 16High number of new directorsThere are 7 new directors who have joined the board in the last 3 years. Director David McInerney was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Buying Opportunity • Nov 11Now 22% undervaluedOver the last 90 days, the stock is up 47%. The fair value is estimated to be €3.38, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 10%. For the next 3 years, revenue is forecast to grow by 10% per annum. Earnings is also forecast to grow by 24% per annum over the same time period.Reported Earnings • Aug 11Second quarter 2022 earnings released: US$0.47 loss per share (vs US$0.46 loss in 2Q 2021)Second quarter 2022 results: US$0.47 loss per share (down from US$0.46 loss in 2Q 2021). Revenue: US$25.8m (up 18% from 2Q 2021). Net loss: US$24.5m (loss widened 4.1% from 2Q 2021). Over the next year, revenue is forecast to grow 5.6%, compared to a 3.6% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 10% per year, which means it is tracking significantly ahead of earnings growth.Recent Insider Transactions • May 25CEO & Director recently bought €88k worth of stockOn the 20th of May, Clinton Lewis bought around 53k shares on-market at roughly €1.64 per share. This was the largest purchase by an insider in the last 3 months. This was Clinton's only on-market trade for the last 12 months.Reported Earnings • May 13First quarter 2022 earnings released: US$0.18 loss per share (vs US$0.029 profit in 1Q 2021)First quarter 2022 results: US$0.18 loss per share (down from US$0.029 profit in 1Q 2021). Revenue: US$39.9m (up 2.3% from 1Q 2021). Net loss: US$9.52m (down US$11.0m from profit in 1Q 2021). Over the next year, revenue is forecast to grow 6.5%, compared to a 6.4% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 10% per year.Board Change • Apr 27High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director John Atkin was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Mar 11Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: US$0.59 loss per share (up from US$1.27 loss in FY 2020). Revenue: US$166.0m (up 5.3% from FY 2020). Net loss: US$30.3m (loss narrowed 53% from FY 2020). Revenue exceeded analyst estimates by 1.7%. Over the next year, revenue is forecast to grow 6.1%, compared to a 4.8% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 13% per year whereas the company’s share price has fallen by 16% per year.Reported Earnings • Nov 11Third quarter 2021 earnings released: US$0.10 loss per share (vs US$0.52 loss in 3Q 2020)The company reported a decent third quarter result with reduced losses and improved control over expenses, although revenues were weaker. Third quarter 2021 results: Revenue: US$49.2m (down 6.8% from 3Q 2020). Net loss: US$5.25m (loss narrowed 80% from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 27% per year, which means it has not declined as severely as earnings.Board Change • Nov 01High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director John Atkin was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Board Change • Oct 02High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director John Atkin was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Aug 11Second quarter 2021 earnings released: US$0.46 loss per share (vs US$0.33 loss in 2Q 2020)The company reported a soft second quarter result with increased losses and weaker control over costs, although revenues improved. Second quarter 2021 results: Revenue: US$21.9m (up 9.7% from 2Q 2020). Net loss: US$23.6m (loss widened 43% from 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings.Executive Departure • Jun 16Independent Investor Director Peter Berweger has left the companyOn the 11th of June, Peter Berweger's tenure as Independent Investor Director ended after less than a year in the role. We don't have any record of a personal shareholding under Peter's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is 1.50 years, which is considered inexperienced in the Simply Wall St Risk Model.Reported Earnings • May 15First quarter 2021 earnings released: EPS US$0.047 (vs US$0.072 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: US$39.0m (up 18% from 1Q 2020). Net income: US$2.42m (up US$6.07m from 1Q 2020). Profit margin: 6.2% (up from net loss in 1Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 34 percentage points per year, which is a significant difference in performance.Analyst Estimate Surprise Post Earnings • Mar 12Revenue misses expectationsRevenue missed analyst estimates by 1.9%. Over the next year, revenue is forecast to grow 5.9%, compared to a 6.0% growth forecast for the Chemicals industry in Germany.Reported Earnings • Mar 12Full year 2020 earnings released: US$1.26 loss per share (vs US$1.21 loss in FY 2019)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: US$157.6m (down 7.3% from FY 2019). Net loss: US$64.2m (loss widened 5.5% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 84% per year but the company’s share price has only fallen by 29% per year, which means it has not declined as severely as earnings.Executive Departure • Feb 25Independent Director has left the companyOn the 18th of February, George Lobisser's tenure as Independent Director ended after 4.4 years in the role. As of December 2020, George personally held 146.91k shares (€282k worth at the time). George is the only executive to leave the company over the last 12 months.Is New 90 Day High Low • Jan 08New 90-day low: €1.69The company is down 24% from its price of €2.22 on 09 October 2020. The German market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 17% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €2.47 per share.Analyst Estimate Surprise Post Earnings • Nov 07Revenue misses expectationsRevenue missed analyst estimates by 18%. Over the next year, revenue is forecast to grow 6.9%, compared to a 2.8% growth forecast for the Chemicals industry in Germany.Reported Earnings • Nov 07Third quarter 2020 earnings released: US$0.52 loss per shareThe company reported a soft third quarter result with weaker earnings and control over expenses, although revenues were improved. Third quarter 2020 results: Revenue: US$52.8m (up 7.8% from 3Q 2019). Net loss: US$26.3m (down US$29.6m from profit in 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 24% per year, which means it has not declined as severely as earnings.Is New 90 Day High Low • Oct 24New 90-day low: €1.91The company is down 5.0% from its price of €2.02 on 24 July 2020. The German market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €6.73 per share.이익 및 매출 성장 예측DB:35X - 애널리스트 향후 추정치 및 과거 재무 데이터 (USD Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/2023181-331939212/31/2022162-601216N/A9/30/2022169-491923N/A6/30/2022171-432125N/A3/31/2022167-412731N/A12/31/2021166-304852N/A9/30/2021162-365053N/A6/30/2021166-654648N/A3/31/2021164-594749N/A12/31/2020158-642427N/A9/30/2020167-772528N/A6/30/2020163-392123N/A3/31/2020164-451012N/A12/31/2019170-541620N/A9/30/2019162-34811N/A6/30/2019182-34913N/A3/31/2019179-3049N/A12/31/2018179-30-13N/A9/30/2018180-5-34N/A6/30/20181722715N/A3/31/2018170232130N/A12/31/2017164232835N/A9/30/2017162-684551N/A6/30/2017162-713339N/A3/31/2017164-982329N/A12/31/2016160-1122430N/A9/30/2016159-43N/A31N/A6/30/2016160-65N/A35N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 35X 의 예상 수익 증가율이 절약률(0.2%)보다 높은지 판단하기에는 데이터가 부족합니다.수익 vs 시장: 35X 의 수익이 German 시장보다 빠르게 성장할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.고성장 수익: 35X 의 수익이 향후 3년 동안 상당히 증가할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.수익 대 시장: 35X 의 수익이 German 시장보다 빠르게 증가할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.고성장 매출: 35X 의 수익이 연간 20%보다 빠르게 증가할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 35X의 자본 수익률이 3년 후 높을 것으로 예상되는지 판단하기에 데이터가 부족합니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2023/04/03 15:39종가2023/03/30 00:00수익2022/12/31연간 수익2022/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스AgroFresh Solutions, Inc.는 4명의 분석가가 다루고 있습니다. 이 중 2명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Joel JacksonBMO Capital Markets Equity ResearchAmit DayalH.C. Wainwright & Co.Benjamin KlieveLake Street Capital Markets, LLC1명의 분석가 더 보기
Reported Earnings • Mar 11Full year 2022 earnings released: US$1.15 loss per share (vs US$0.59 loss in FY 2021)Full year 2022 results: US$1.15 loss per share (further deteriorated from US$0.59 loss in FY 2021). Revenue: US$161.9m (down 2.4% from FY 2021). Net loss: US$59.8m (loss widened 97% from FY 2021). Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth.
Buying Opportunity • Nov 19Now 20% undervaluedOver the last 90 days, the stock is up 50%. The fair value is estimated to be €3.34, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 4.9%. For the next 3 years, revenue is forecast to grow by 10% per annum. Earnings is also forecast to grow by 30% per annum over the same time period.
Board Change • Nov 16High number of new directorsThere are 7 new directors who have joined the board in the last 3 years. Director David McInerney was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Buying Opportunity • Nov 11Now 22% undervaluedOver the last 90 days, the stock is up 47%. The fair value is estimated to be €3.38, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 10%. For the next 3 years, revenue is forecast to grow by 10% per annum. Earnings is also forecast to grow by 24% per annum over the same time period.
Reported Earnings • Aug 11Second quarter 2022 earnings released: US$0.47 loss per share (vs US$0.46 loss in 2Q 2021)Second quarter 2022 results: US$0.47 loss per share (down from US$0.46 loss in 2Q 2021). Revenue: US$25.8m (up 18% from 2Q 2021). Net loss: US$24.5m (loss widened 4.1% from 2Q 2021). Over the next year, revenue is forecast to grow 5.6%, compared to a 3.6% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 10% per year, which means it is tracking significantly ahead of earnings growth.
Recent Insider Transactions • May 25CEO & Director recently bought €88k worth of stockOn the 20th of May, Clinton Lewis bought around 53k shares on-market at roughly €1.64 per share. This was the largest purchase by an insider in the last 3 months. This was Clinton's only on-market trade for the last 12 months.
Reported Earnings • May 13First quarter 2022 earnings released: US$0.18 loss per share (vs US$0.029 profit in 1Q 2021)First quarter 2022 results: US$0.18 loss per share (down from US$0.029 profit in 1Q 2021). Revenue: US$39.9m (up 2.3% from 1Q 2021). Net loss: US$9.52m (down US$11.0m from profit in 1Q 2021). Over the next year, revenue is forecast to grow 6.5%, compared to a 6.4% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 10% per year.
Board Change • Apr 27High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director John Atkin was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Mar 11Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: US$0.59 loss per share (up from US$1.27 loss in FY 2020). Revenue: US$166.0m (up 5.3% from FY 2020). Net loss: US$30.3m (loss narrowed 53% from FY 2020). Revenue exceeded analyst estimates by 1.7%. Over the next year, revenue is forecast to grow 6.1%, compared to a 4.8% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 13% per year whereas the company’s share price has fallen by 16% per year.
Reported Earnings • Nov 11Third quarter 2021 earnings released: US$0.10 loss per share (vs US$0.52 loss in 3Q 2020)The company reported a decent third quarter result with reduced losses and improved control over expenses, although revenues were weaker. Third quarter 2021 results: Revenue: US$49.2m (down 6.8% from 3Q 2020). Net loss: US$5.25m (loss narrowed 80% from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 27% per year, which means it has not declined as severely as earnings.
Board Change • Nov 01High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director John Atkin was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Board Change • Oct 02High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director John Atkin was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Aug 11Second quarter 2021 earnings released: US$0.46 loss per share (vs US$0.33 loss in 2Q 2020)The company reported a soft second quarter result with increased losses and weaker control over costs, although revenues improved. Second quarter 2021 results: Revenue: US$21.9m (up 9.7% from 2Q 2020). Net loss: US$23.6m (loss widened 43% from 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings.
Executive Departure • Jun 16Independent Investor Director Peter Berweger has left the companyOn the 11th of June, Peter Berweger's tenure as Independent Investor Director ended after less than a year in the role. We don't have any record of a personal shareholding under Peter's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is 1.50 years, which is considered inexperienced in the Simply Wall St Risk Model.
Reported Earnings • May 15First quarter 2021 earnings released: EPS US$0.047 (vs US$0.072 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: US$39.0m (up 18% from 1Q 2020). Net income: US$2.42m (up US$6.07m from 1Q 2020). Profit margin: 6.2% (up from net loss in 1Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 34 percentage points per year, which is a significant difference in performance.
Analyst Estimate Surprise Post Earnings • Mar 12Revenue misses expectationsRevenue missed analyst estimates by 1.9%. Over the next year, revenue is forecast to grow 5.9%, compared to a 6.0% growth forecast for the Chemicals industry in Germany.
Reported Earnings • Mar 12Full year 2020 earnings released: US$1.26 loss per share (vs US$1.21 loss in FY 2019)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: US$157.6m (down 7.3% from FY 2019). Net loss: US$64.2m (loss widened 5.5% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 84% per year but the company’s share price has only fallen by 29% per year, which means it has not declined as severely as earnings.
Executive Departure • Feb 25Independent Director has left the companyOn the 18th of February, George Lobisser's tenure as Independent Director ended after 4.4 years in the role. As of December 2020, George personally held 146.91k shares (€282k worth at the time). George is the only executive to leave the company over the last 12 months.
Is New 90 Day High Low • Jan 08New 90-day low: €1.69The company is down 24% from its price of €2.22 on 09 October 2020. The German market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 17% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €2.47 per share.
Analyst Estimate Surprise Post Earnings • Nov 07Revenue misses expectationsRevenue missed analyst estimates by 18%. Over the next year, revenue is forecast to grow 6.9%, compared to a 2.8% growth forecast for the Chemicals industry in Germany.
Reported Earnings • Nov 07Third quarter 2020 earnings released: US$0.52 loss per shareThe company reported a soft third quarter result with weaker earnings and control over expenses, although revenues were improved. Third quarter 2020 results: Revenue: US$52.8m (up 7.8% from 3Q 2019). Net loss: US$26.3m (down US$29.6m from profit in 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 24% per year, which means it has not declined as severely as earnings.
Is New 90 Day High Low • Oct 24New 90-day low: €1.91The company is down 5.0% from its price of €2.02 on 24 July 2020. The German market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €6.73 per share.